Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Probucol and Cilostazol Coadministration
NCT00549978Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of probucol and cilostazol in hypercholesterolemia and intermittent claudication (IC) (2 arms), sponsored by Otsuka Holdings. Primary endpoints: Pharmacokinetic parameters and Number of adverse events. Started Oct 2007; status: completed.
02
Drugs
probucolcilostazol
03
Conditions
hypercholesterolemiaintermittent claudication (IC)
Beyond the preview
Go deeper on NCT00549978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549978.